meta_pixel
Tapesearch Logo
Log in
Odd Lots

D.A. Wallach Explains Why Biotech VC Is So Different

Odd Lots

Bloomberg

News, Investing, Business, News Commentary, Business News

4.41.6K Ratings

🗓️ 12 December 2025

⏱️ 55 minutes

🧾️ Download transcript

Summary

Most people think of venture capital as funding software startups or, these days, some new AI tool. But VC also plays a major role in developing new medicines and treatments. That’s the world of D.A. Wallach — though he didn’t start there. Before becoming a biotech investor, Wallach was the lead singer of the indie rock band Chester French. So how did he make the leap from music to venture capital? How does he spot promising biotech opportunities? What does it actually take to bring a new drug to market? And how does biotech investing differ from traditional VC? We talk to the co-founder of Time BioVentures about all of this — plus we get his thoughts on AI’s impact on music and a special performance.

Have a question for Joe and Tracy?  Now's your chance to be the perfect guest  - record a voice memo with your name, age, location and question and email to [email protected] for a chance to be included in the holiday AMA episode.

Read More:
Big Pharma’s Patent Cliff Puts China Front and Center
Novartis Strikes Deal With UK Biotech for Up To $1.7 Billion

Join the conversation: discord.gg/oddlots

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0

You're being sold an AI future where you're obsolete or irrelevant.

0:04.0

That vision is wrong.

0:06.0

At Palantir, they're building AI that helps workers and unlocks their full potential.

0:12.0

American workers are our nation's greatest strength.

0:16.0

AI shouldn't eliminate them. It should elevate them.

0:19.0

Palantir is here to tell their stories. From factories

0:23.0

to hospitals, AI is freeing people from drudgery, letting them do what humans do best. Create, solve,

0:31.0

build. Palantir, making Americans irreplaceable. This is Tom Keen, inviting you to join me for the Bloomberg Surveillance Podcast.

0:40.6

It's about making you smarter each and every business day.

0:44.2

We bring you a recap of what happened overnight in Europe and Asia, the day's economic

0:49.5

data, and complete coverage of the U.S. market open.

0:53.2

We cover stocks, bonds, commodities, currencies,

0:56.3

even crypto, all the information you need to excel. Bloomberg's surveillance also brings you the

1:02.4

analysis behind the headlines. We do that with lengthy conversations with our expert guests,

1:08.2

the smartest names in economics, finance investment, and international

1:12.3

relations. We do all this live each and every weekday, then bring you the best analysis

1:18.1

in our daily podcast. Search for Bloomberg surveillance on YouTube, Apple, Spotify, or anywhere

1:25.3

else you listen. On the East Coast, listen at lunch, and on the West Coast when you wake up.

1:30.7

That's the Bloomberg Surveillance podcast with me, Tom Keene, along with Paul Sweeney and Lisa

1:36.2

Mateo.

1:37.1

Subscribe today, wherever you get your podcast.

1:42.4

Hey there, Oddlots listeners. It is that time of the year. Again, we are going to be doing a call-in show on the podcast. You can ask us any of your burning questions.

...

Transcript will be available on the free plan in 25 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.